The Fifth Annual Les Turner Symposium on ALS and NeuroRepair celebrated a new research and clinical care center and featured a variety of presentations, a keynote lecture and a poster session.
Northwestern Medicine scientists have identified a novel strategy for reducing the side effects of the drug levodopa, which is commonly used to treat the stiffness, tremors and poor muscle control of Parkinson’s disease.
People who ate more fruits and vegetables as young adults were less likely to develop coronary atherosclerosis 20 years later, according to a recent study co-authored by Northwestern Medicine investigator Philip Greenland, MD.
Marcus Peter, PhD, professor of Medicine in the Division of Hematology/Oncology, and Ali Shilatifard, PhD, chair of Biochemistry and Molecular Genetics, and Maciej Lesniak, MD, chair of Neurological Surgery, have each been awarded seven-year, $6.4 million grants from the National Cancer Institute.
Northwestern Medicine scientists identified a drug that stops the reproduction of tumor cells in models of primary myelofibrosis and acute myeloid leukemia, a finding that has led to new clinical studies in the Lurie Cancer Center.
The contest showcases a breadth of research across disciplines; the first place winner is a collaboration between postdoctoral fellows in Obstetrics and Gynecology and Materials Science and Engineering.
Providing individualized feedback about the risk of developing cardiovascular disease to community health center patients increased treatment discussions with primary care physicians, according to a new Northwestern Medicine study.
A recent study co-authored by Northwestern Medicine scientists demonstrates the molecular mechanisms that may underlie left ventricular hypertrophy, a pattern of cardiac injury common in patients with chronic kidney disease.
Northwestern Medicine scientists showed how the herpes simplex virus exploits microtubule plus-end tracking proteins to move within human cells, providing insights into how viruses engage with host transport networks.
Lindsay Stolzenburg, a PhD student in the Driskill Graduate Program in Life Sciences, studies the role of microRNAs to identify target genes that may be involved in cystic fibrosis.